Abstract
This study aims to estimate plasma levels of acylated ghrelin in children with pulmonary hypertension (PH) associated with congenital heart disease (CHD) and to correlate the levels of acylated ghrelin with endothelin-1 (ET-1), nitric oxide (NO), and clinical hemodynamic parameters. We investigated the plasma concentration of acylated ghrelin, ET-1, NO, and the hemodynamic parameters in 20 children with CHD, 20 children with PH-CHD, and 20 normal children. Plasma-acylated ghrelin and NO levels were significantly higher in CHD group than in control subjects (P < 0.001). Moreover, plasma-acylated ghrelin, ET-1, and NO levels were significantly elevated in PH-CHD group compared with the CHD group (P < 0.05). In PH-CHD children, plasma-acylated ghrelin levels correlated positively with pulmonary artery systolic pressure (PASP; r = 0.740, P < 0.001), pulmonary artery diastolic pressure (PADP; r = 0.613, P = 0.004), right ventricular systolic pressure (RVSP; r = 0.642, P = 0.002), mean pulmonary arterial hypertension (mPAP; r = 0.685, P = 0.001), right ventricle diameter (RVD; r = 0.473, P = 0.035), pulmonary artery trunk diameter (PAD; r = 0.613, P = 0.004), NO (r = 0.463, P = 0.04), and ET-1 (r = 0.524, P = 0.018). Plasma-acylated ghrelin levels were elevated both in CHD and in PH-CHD. Increased acylated ghrelin levels correlated positively with ET-1, NO, PASP, PADP, RVSP, mPAP, RVD, and PAD. Acylated ghrelin may be a new biomarker of PH-CHD.
Similar content being viewed by others
References
Afify MF, Mohamed GB, El-Maboud MA, Abdel-Latif EA (2009) Serum levels of ghrelin, tumor necrosis factor-alpha and interleukin-6 in infants and children with congenital heart disease. J Trop Pediatr 55:388–392
Akamizu T, Shinomiya T, Irako T, Fukunaga M, Nakai Y, Nakai Y, Kangawa K (2005) Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay. J Clin Endocrinol Metab 90:6–9
Al Massadi O, Lear PV, Müller TD, Lopez M, Dieguez C, Tschop MH, Nogueiras R (2014) Review of novel aspects of the regulation of ghrelin secretion. Curr Drug Metab 15:398–413
Amabile N, Guignabert C, Montani D, Yeghiazarians Y, Boulanger CM, Humbert M (2013) Cellular microparticles in the pathogenesis of pulmonary hypertension. Eur Respir J 42:272–279
Attanasio P, Anker SD, Doehner W, von Haehling S (2011) Hormonal consequences and prognosis of chronic heart failure. Curr Opin Endocrinol Diabetes Obes 18:224–230
Barst RJ, Ertel SI, Beghetti M, Ivy DD (2011) Pulmonary arterial hypertension: a comparison between children and adults. Eur Respir J 37:665–677
Coggins MP, Bloch KD (2007) Nitric oxide in the pulmonary vasculature. Arterioscler Thromb Vasc Biol 27:1877–1885
Cummings DE, Shannon MH (2003) Roles for ghrelin in the regulation of appetite and body weight. Arch Surg 138:389–3961
Currie PJ, Seward JB, Chan KL, Fyfe DA, Hagler DJ, Mair DD, Reeder GS, Nishimura RA, Tajik AJ (1985) Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. J Am Coll Cardiol 6:750–756
Feltes TF, Bacha E, Beekman RH 3rd et al (2011) Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation 123:2607–2652
Granata R, Isgaard J, Alloatti G, Ghigo E (2011) Cardiovascular actions of the ghrelin gene-derived peptides and growth hormone-releasing hormone. Exp Biol Med (Maywood) 236:505–514
Gupta V, Tonelli AR, Krasuski RA (2012) Congenital heart disease and pulmonary hypertension. Heart Fail Clin 8:427–445
Henriques-Coelho T, Correia-Pinto J, Roncon-Albuquerque R Jr, Baptista MJ, Lourenço AP, Oliveira SM, Brandão-Nogueira A, Teles A, Fortunato JM, Leite-Moreira AF (2004) Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 287:H2885–H2890
Heppner KM, Tong J, Kirchner H, Nass R, Tschöp MH (2011) The ghrelin O-acyltransferase–ghrelin system: a novel regulator of glucose metabolism. Curr Opin Endocrinol Diabetes Obes 18:50–55
Iantorno M, Chen H, Kim JA, Tesauro M, Lauro D, Cardillo C, Quon MJ (2007) Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells. Am J Physiol Endocrinol Metab 292:E756–E764
Jarkovska Z, Rosicka M, Krsek M, Sulkova S, Haluzik M, Justova V, Lacinova Z, Marek J (2005) Plasma ghrelin levels in patients with end-stage renal disease. Physiol Res 54:403–408
Kabil NN, Seddiek HA, Yassin NA, Gamal-Eldin MM (2014) Effect of ghrelin on chronic liver injury and fibrogenesis in male rats: possible role of nitric oxide. Peptides 52:90–97
Kandil ME, Elwan A, Hussein Y, Kandeel W, Rasheed M (2009) Ghrelin levels in children with congenital heart disease. J Trop Pediatr 55:307–312
Kim YS, Lee JS, Lee TH, Cho JY, Kim JO, Kim WJ, Kim HG, Jeon SR, Jeong HS (2012) Plasma levels of acylated ghrelin in patients with functional dyspepsia. World J Gastroenterol 18:2231–2237
Kishimoto I, Tokudome T, Hosoda H, Miyazato M, Kangawa K (2012) Ghrelin and cardiovascular diseases. J Cardiol 59:8–13
Legakis I, Stathopoulos J, Matzouridis T, Stathopoulos GP (2009) Decreased plasma ghrelin levels in patients with advanced cancer and weight loss in comparison to healthy individuals. Anticancer Res 29:3949–3952
Leite-Moreira AF, Soares JB (2007) Physiological, pathological and potential therapeutic roles of ghrelin. Drug Discov Today 12:276–288
Li ZF, Zhou DX, Pan WZ, Zhang L, Ge JB (2013) Circulating ghrelin was negatively correlated with pulmonary arterial pressure in atrial septal defect patients. Chin Med J 126:3936–3939
Lopez L, Colan SD, Frommelt PC, Ensing GJ, Kendall K, Younoszai AK, Lai WW, Geva T (2010) Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr 23:465–495 quiz 576–577
Lourenço AP, Fontoura D, Henriques-Coelho T, Leite-Moreira AF (2012) Current pathophysiological concepts and management of pulmonary hypertension. Int J Cardiol 155:350–361
Lund LH, Williams JJ, Freda P, LaManca JJ, LeJemtel TH, Mancini DM (2009) Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation. Eur J Heart Fail 11:789–794
Mao Y, Tokudome T, Kishimoto I (2014) Ghrelin as a treatment for cardiovascular diseases. Hypertension 64:450–454
Nagaya N, Moriya J, Yasumura Y, Uematsu M, Ono F, Shimizu W, Ueno K, Kitakaze M, Miyatake K, Kangawa K (2004) Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 110:3674–3679
Rocha-Sousa A, Pereira-Silva P, Tavares-Silva M, Azevedo-Pinto S, Rodrigues-Araújo J, Pinho S, Avelino A, Falcão-Reis F, Leite-Moreira A (2014) Identification of the ghrelin-GHSR 1 system and its influence in the modulation of induced ocular hypertension in rabbit and rat eyes. Peptides 57:59–66
Rodriguez A, Gomez-Ambrosi J, Catalan V, Becerril S, Sáinz N, Gil MJ, Silva C, Salvador J, Barba J, Colina I, Frühbeck G (2010) Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome. J Hypertens 28:560–567
Schwenke DO, Gray EA, Pearson JT, Sonobe T, Ishibashi-Ueda H, Campillo I, Kangawa K, Umetani K, Shirai M (2011) Exogenous ghrelin improves blood flow distribution in pulmonary hypertension-assessed using synchrotron radiation microangiography. Pflugers Arch 462:397–406
Stephen B, Dalal P, Berger M, Schweitzer P, Hecht S (1999) Noninvasive estimation of pulmonary artery diastolic pressure in patients with tricuspid regurgitation by Doppler echocardiography. Chest 116:73–77
Tesauro M, Schinzari F, Iantorno M, Rizza S, Melina D, Lauro D, Cardillo C (2005) Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation 112:2986–2992
Tesauro M, Schinzari F, Rovella V, Di Daniele N, Lauro D, Mores N, Veneziani A, Cardillo C (2009) Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome. Hypertension 54:995–1000
Tokudome T, Kishimoto I, Miyazato M, Kangawa K (2014) Ghrelin and the cardiovascular system. Front Horm Res 43:125–133
Ueno H, Yamaguchi H, Kangawa K, Nakazato M (2005) Ghrelin: a gastric peptide that regulates food intake and energy homeostasis. Regul Pept 126:11–19
Wiley KE, Davenport AP (2002) Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br J Pharmacol 136:1146–1152
Wu R, Chaung WW, Dong W, Ji Y, Barrera R, Nicastro J, Molmenti EP, Coppa GF, Wang P (2012) Ghrelin maintains the cardiovascular stability in severe sepsis. J Surg Res 178:370–377
Xu X, Jhun BS, Ha CH, Jin ZG (2008) Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation. Endocrinology 149:4183–4192
Yang D, Liu Z, Yang Z (2013) Ghrelin and its relation with N-terminal brain natriuretic peptide, endothelin-1 and nitric oxide in patients with idiopathic pulmonary hypertension. Cardiology 124:241–245
Yang D, Liu Z, Zhang H, Luo Q (2013) Ghrelin protects human pulmonary artery endothelial cells against hypoxia-induced injury via PI3-kinase/Akt. Peptides 42:112–117
Yilmaz E, Ustundag B, Sen Y, Akarsu S, Kurt AN, Dogan Y (2007) The levels of Ghrelin, TNF-alpha, and IL-6 in children with cyanotic and acyanotic congenital heart disease. Mediators Inflamm 2007:32403
Acknowledgments
We thank Ying Fan (Department of Ultrasound, the Affiliated Hospital of Luzhou Medical College, Luzhou, China). This study was supported by the Talent Foundation of the affiliated Hospital of Luzhou Medical College (2012).
Conflict of interest
The authors have no conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Additional information
Gang Li and Jiyi Xia have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Li, G., Xia, J., Jia, P. et al. Plasma Levels of Acylated Ghrelin in Children with Pulmonary Hypertension Associated with Congenital Heart Disease. Pediatr Cardiol 36, 1423–1428 (2015). https://doi.org/10.1007/s00246-015-1178-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-015-1178-5